GlassScriptPhysician profile
Julia Wrona
NPI 1346881927
$10,189.43
in general payments reported to CMS, 2019-2025
34 companies · $1,313 in 2025
The $1,313 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,353 · 2022: $2,146 · 2023: $2,520 · 2024: $2,857 · 2025: $1,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,511 · Travel and Lodging: $1,170 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,511.46 |
| Travel and Lodging | $1,169.87 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,018.60 | 2021-2025 | Linq II, Micra, Reveal Linq |
| Novartis Pharmaceuticals Corporation | $875.57 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $819.00 | 2021-2024 | Xarelto |
| Edwards Lifesciences Corporation | $767.13 | 2021-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| United Therapeutics Corporation | $484.28 | 2021-2025 | Tyvaso, Tyvaso, Orenitram |
| Merck Sharp & Dohme LLC | $447.88 | 2021-2025 | Verquvo, Winrevair, Belsomra |
| Boston Scientific Corporation | $410.93 | 2023-2024 | Watchman Access System, Impulse |
| Actelion Pharmaceuticals US, INC. | $398.24 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Bayer Healthcare Pharmaceuticals INC. | $388.94 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $347.48 | 2021-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $250.48 | 2021-2024 | Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $221.23 | 2023-2025 | Camzyos, Eliquis |
| Scpharmaceuticals INC. | $215.86 | 2024-2025 | |
| Atricure, INC. | $202.25 | 2024-2025 | Atriclip Laa Exclusion System |
| Abbott Laboratories | $167.38 | 2022-2023 | Amplatzer Talisman |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $153.26 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $142.22 | 2022-2023 | Lifevest |
| Amgen INC. | $141.91 | 2021-2024 | Repatha |
| Alnylam Pharmaceuticals INC. | $126.76 | 2023-2024 | Onpattro, Amvuttra |
| Esperion Therapeutics, INC. | $119.20 | 2021-2025 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $86.25 | 2023-2024 | Inpefa |
| Novo Nordisk INC | $76.35 | 2025 | Wegovy |
| Bridgebio Pharma, INC. | $62.51 | 2025 | Attruby |
| Irhythm Technologies, INC. | $45.82 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Shockwave Medical, INC | $45.78 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kiniksa Pharmaceuticals International, Plc | $31.84 | 2024 | Arcalyst |
| W. L. Gore & Associates, INC. | $24.90 | 2023 | Gore Cardioform Septal Occluder |
| Terumo Medical Corporation | $19.39 | 2024 | Angio-Seal |
| Kowa Pharmaceuticals America, INC. | $18.46 | 2021 | |
| Tactile Systems Technology INC | $18.02 | 2022 | |
| Chiesi USA, INC. | $17.21 | 2024 | Kengreal, Cleviprex |
| Cardiva Medical, INC. | $16.42 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Regeneron Healthcare Solutions, INC. | $14.62 | 2025 | Evkeeza |
| Kiniksa Pharmaceuticals, LTD. | $13.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Wrona listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.